Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$67.74
-2.5%
$82.32
$62.34
$141.99
$26.47B1.284.06 million shs4.68 million shs
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$70.90
-0.4%
$71.49
$58.93
$95.73
$41.85B1.124.81 million shs4.51 million shs
General Electric stock logo
GE
General Electric
$199.66
-3.0%
$201.52
$133.99
$214.21
$214.53B1.195.49 million shs5.18 million shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$80.01
-2.0%
$86.70
$74.51
$94.80
$36.59B1.132.93 million shs3.19 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
0.00%-8.21%-22.86%-15.58%-51.43%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
0.00%+0.63%-0.74%-6.28%-25.49%
General Electric stock logo
GE
General Electric
0.00%-2.13%-0.87%+17.39%+10.85%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.00%-1.82%-10.50%+0.63%-11.41%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
DexCom, Inc. stock logo
DXCM
DexCom
4.8925 of 5 stars
4.43.00.04.73.52.51.9
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
4.6138 of 5 stars
3.23.00.04.03.02.52.5
General Electric stock logo
GE
General Electric
4.4902 of 5 stars
2.55.01.72.83.51.71.9
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
3.6396 of 5 stars
2.44.01.70.03.61.72.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
2.89
Moderate Buy$99.8247.36% Upside
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
2.40
Hold$79.9512.77% Upside
General Electric stock logo
GE
General Electric
2.94
Moderate Buy$211.315.84% Upside
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
2.77
Moderate Buy$98.7523.42% Upside

Current Analyst Ratings Breakdown

Latest GEHC, GE, EW, and DXCM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/21/2025
DexCom, Inc. stock logo
DXCM
DexCom
Cfra Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
3/11/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$85.00 ➝ $100.00
3/8/2025
DexCom, Inc. stock logo
DXCM
DexCom
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
3/4/2025
DexCom, Inc. stock logo
DXCM
DexCom
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$101.00 ➝ $104.00
2/18/2025
General Electric stock logo
GE
General Electric
Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$250.00
2/14/2025
DexCom, Inc. stock logo
DXCM
DexCom
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$75.00 ➝ $82.00
2/14/2025
DexCom, Inc. stock logo
DXCM
DexCom
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$99.00 ➝ $103.00
2/14/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$96.00 ➝ $103.00
2/13/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$88.00 ➝ $90.00
2/13/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$68.00 ➝ $71.00
2/13/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$103.00 ➝ $110.00
(Data available from 3/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.03B6.56$1.70 per share39.75$5.38 per share12.59
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$5.44B7.66$2.62 per share27.04$11.08 per share6.40
General Electric stock logo
GE
General Electric
$38.70B5.54$5.54 per share36.03$18.23 per share10.95
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$19.67B1.86$5.02 per share15.94$18.51 per share4.32
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$576.20M$1.4347.3727.542.3014.29%30.14%10.11%4/24/2025 (Estimated)
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$4.17B$6.9710.1725.784.8272.93%19.40%14.37%4/24/2025 (Estimated)
General Electric stock logo
GE
General Electric
$6.56B$5.9933.3330.912.5914.31%22.19%3.66%4/22/2025 (Estimated)
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.99B$4.3318.4815.393.1910.13%25.74%6.29%4/29/2025 (Estimated)

Latest GEHC, GE, EW, and DXCM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2025N/A
DexCom, Inc. stock logo
DXCM
DexCom
$0.33N/AN/AN/A$1.02 billionN/A
4/24/2025N/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.60N/AN/AN/A$1.40 billionN/A
4/22/2025N/A
General Electric stock logo
GE
General Electric
$1.29N/AN/AN/A$9.06 billionN/A
2/13/2025Q4 2024
DexCom, Inc. stock logo
DXCM
DexCom
$0.50$0.45-$0.05$0.38$1.10 billionN/A
2/13/2025Q4 2024
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.26$1.45+$0.19$1.57$5.33 billion$5.32 billion
2/11/2025Q4 2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.55$0.59+$0.04$0.65$1.36 billionN/A
1/23/2025Q4 2024
General Electric stock logo
GE
General Electric
$1.05$1.32+$0.27$1.75$9.68 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
General Electric stock logo
GE
General Electric
$1.440.72%+51.83%24.04%N/A
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.140.17%N/A3.23%N/A

Latest GEHC, GE, EW, and DXCM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/27/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
quarterly$0.03500.17%4/25/20254/25/20255/15/2025
2/14/2025
General Electric stock logo
GE
General Electric
quarterly$0.360.69%3/10/20253/10/20254/25/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.59
1.47
1.28
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
0.06
3.46
2.89
General Electric stock logo
GE
General Electric
0.88
1.09
0.81
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.88
1.04
0.83

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
79.46%
General Electric stock logo
GE
General Electric
74.77%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
82.06%

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.30%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
1.29%
General Electric stock logo
GE
General Electric
0.21%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.27%
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
7,600390.77 million389.60 millionOptionable
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
17,300587.90 million582.19 millionOptionable
General Electric stock logo
GE
General Electric
172,0001.07 billion1.07 billionOptionable
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
50,000457.30 million456.06 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
DexCom stock logo

DexCom NASDAQ:DXCM

$67.74 -1.73 (-2.49%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$68.04 +0.30 (+0.44%)
As of 03/28/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$70.90 -0.29 (-0.41%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$70.92 +0.03 (+0.04%)
As of 03/28/2025 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

General Electric stock logo

General Electric NYSE:GE

$199.66 -6.22 (-3.02%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$199.47 -0.19 (-0.09%)
As of 03/28/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

General Electric Company, doing business as GE Aerospace, designs and produces commercial and defense aircraft engines, integrated engine components, electric power, and mechanical aircraft systems. It also offers aftermarket services to support its products. The company operates in the United States, Europe, China, Asia, the Americas, the Middle East, and Africa. General Electric Company was incorporated in 1892 and is based in Evendale, Ohio.

GE HealthCare Technologies stock logo

GE HealthCare Technologies NASDAQ:GEHC

$80.01 -1.65 (-2.02%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$79.88 -0.13 (-0.16%)
As of 03/28/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.